Market Research Logo

Norway Pharmaceuticals & Healthcare Q1 2019

Norway Pharmaceuticals & Healthcare Q1 2019

Key View:

Ongoing efforts by Norway and Denmark to jointly negotiate the price of selected medicines pose downside risks todrugmakers seeking to launch an innovative medicine in these countries' pharmaceutical markets. In fact, Norway's stringent drugpricing policies will continue to limit drugmaker opportunities, despite sustained market growth. On the upside, an ageingpopulation and the rising demand for chronic disease treatment underpin market growth fundamentals, which will be supported byhigh expenditure on healthcare.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Norway Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Norway Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report